Sino Biopharmaceutical Ltd (1177) - Strategic SWOT Analysis Review

May 2020 | 40 pages | ID: S1EA08DD1CA7EN
GlobalData

Abstracts

Sino Biopharmaceutical Ltd (1177) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Sino Biopharmaceutical Ltd (Sino Biopharma), a subsidiary of CP Pharmaceutical Group, is a research driven pharmaceutical company that develops, manufactures, and markets chemicals, biopharmaceuticals and Chinese medicines. It offers medicines for the treatment of hepatitis, cardio-cerebral diseases, cancer, orthopedic diseases, infectious diseases, diabetes, respiratory and digestive diseases. The company offers its products in various dosage forms including large volume injections, PVC-free soft bags for intravenous (IV) injections, small volume injections, powdered medicines, granulated medicines, capsules and tablets. It works in partnership with several domestic and foreign pharmaceutical companies to advance the development of its products. Sino Biopharma along with its subsidiaries is headquartered in Hong Kong.

Sino Biopharmaceutical Ltd Key Recent Developments

Mar 30,2020: Sino Biopharm announces 2019 annual results
Feb 19,2020: KWM advises on Sino Biopharmaceutical’s €750 million convertible bonds

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Sino Biopharmaceutical Ltd - Key Facts
Sino Biopharmaceutical Ltd - Key Employees
Sino Biopharmaceutical Ltd - Key Employee Biographies
Sino Biopharmaceutical Ltd - Major Products and Services
Sino Biopharmaceutical Ltd - History
Sino Biopharmaceutical Ltd - Company Statement
Sino Biopharmaceutical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Sino Biopharmaceutical Ltd - Business Description
Product Category: Analgesic Medicines
Overview
Performance
Product Category: Anti-infectious Medicines
Overview
Performance
Product Category: Cardio-Cerebral Medicines
Overview
Performance
Product Category: Diabetic Medicines
Overview
Performance
Product Category: Digestive System Medicines
Overview
Performance
Product Category: Hepatitis Medicines
Overview
Performance
Product Category: Oncology Medicines
Overview
Performance
Product Category: Orthopedic Medicines
Overview
Performance
Product Category: Parenteral Nutritious Medicines
Overview
Performance
Product Category: Respiratory System Medicines
Overview
Performance
R&D Overview
Sino Biopharmaceutical Ltd - Corporate Strategy
Sino Biopharmaceutical Ltd - SWOT Analysis
SWOT Analysis - Overview
Sino Biopharmaceutical Ltd - Strengths
Sino Biopharmaceutical Ltd - Weaknesses
Sino Biopharmaceutical Ltd - Opportunities
Sino Biopharmaceutical Ltd - Threats
Sino Biopharmaceutical Ltd - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sino Biopharmaceutical Ltd, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 30, 2020: Sino Biopharm announces 2019 annual results
Feb 19, 2020: KWM advises on Sino Biopharmaceutical’s €750 million convertible bonds

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Sino Biopharmaceutical Ltd, Key Facts
Sino Biopharmaceutical Ltd, Key Employees
Sino Biopharmaceutical Ltd, Key Employee Biographies
Sino Biopharmaceutical Ltd, Major Products and Services
Sino Biopharmaceutical Ltd, History
Sino Biopharmaceutical Ltd, Other Locations
Sino Biopharmaceutical Ltd, Subsidiaries
Sino Biopharmaceutical Ltd, Key Competitors
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sino Biopharmaceutical Ltd, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sino Biopharmaceutical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Tibet Rhodiola Pharmaceutical Holding Co Ltd
The United Laboratories International Holdings Ltd
Shenzhen Accord Pharmaceutical Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Guizhou YiBai Pharmaceutical Co Ltd
Dawnrays Pharmaceutical (Holdings) Ltd
China Resources Pharmaceutical Group Ltd